Pharmaceutical Executive-01-13-2009

Trending on PharmExec

FDA Approves Fayuvi for Pediatric Patients with Sanfilippo Syndrome Type A

M&A Roundup: Lisata Therapeutics Acquires Marea Therapeutics, mAbxience Enters Collaboration with Sandoz

The Battle to Own the GLP-1 Patient Journey

Novo Announces Drug Discovery Collaboration with Anthropic

FDA Approves Kerendia for Adults with Chronic Kidney Disease and Type 1 Diabetes